Company Financials
NextGen Healthcare, Inc. Financials
Israeli shekel
business
NextGen Healthcare, Inc. Company Profile
Main Stock Listing
NASDAQ: NXGN
Market Capitalization $1.61 Billion as of Nov. 1, 2023
Market Cap History
Valuations Metrics as of Jul. 5, 2025
| Trailing PE | |
| Forward PE | |
| Price to Sales TTM | ₪ |
| Price to Book MRQ | ₪ |
| Enterprise to Revenue | |
| Enterprise to EBITDA | -1.16 |
Financial Reports as of Dec. 31, 2024
Financials
| Fiscal Year Ends | 2024-12-31 |
| Most Recent Quarter | 2024-12-31 |
| Profit Margin | 0.00% |
| Operating Margin | 0.00% |
| Return on Assets TTM | -728.92% |
| Return on Equity TTM | 198.46% |
Income Statement
| Revenue TTM | ₪0 |
| Revenue per Share TTM | ₪ |
| Quarterly Revenue Growth | % |
| Gross Profit TTM | ₪0 |
| EBITDA | ₪None |
| Net Income to Common TTM | ₪-4,892,000 |
| Diluted EPS TTM | ₪-0.58 |
| Quarterly Earnings Growth YoY | % |
Balance Sheet
| Total Cash MRQ | ₪47,000 |
| Total Cash per Share MRQ | ₪0.00 |
| Total Debt MRQ | ₪ |
| Total Debt to Equity MRQ | -0.09 |
| Current Ratio MRQ | 0.08 |
| Book Value per Share MRQ | ₪-0.22 |
Cash Flow
| Operating Cash Flow TTM | ₪-3,980,000 |
| Levered Free Cash Flow TTM | ₪-4,892,000 |
NXGN Stock Info as of Jul. 5, 2025
Stock Statistics
| Shares Outstanding | 7,263,379 |
| Float Shares | 9,206,595 |
| Avg 10 Volume | 61,931 |
| Avg 30 Volume | None |
| Shares Short | None |
| Short Ratio | |
| Short % of Shares | % |
| % Held by Insiders | 15.55% |
| % Held by Institutions | 7.83% |
Stock Price Summary
| Beta | 1.04 |
| Fifty Two Week Low | ₪48.00 |
| Fifty Two Week High | ₪125.00 |
| Fifty Two Week Change | -109.32% |
| Day 50 MA | ₪55.10 |
| Day 200 MA | ₪62.75 |
Dividends and Splits
| Forward Annual Dividend Rate | ₪ |
| Forward Annual Dividend Yield | % |
| Trailing Annual Dividend Rate | ₪0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Dividend Date | |
| Ex Dividend Date | |
| Last Split Factor | |
| Last Split Date | 2023-09-03 |